Exact Sciences Corporation (NASDAQ:EXAS) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 1:30 PM EDT
Company Participants
Aaron Bloomer – Chief Financial Officer
Conference Call Participants
Brandon Couillard – Wells Fargo Securities, LLC, Research Division
Presentation
Brandon Couillard
MD & Equity Analyst
All right. Good afternoon. Welcome to the Wells Fargo Healthcare Conference. I’m Brandon Couillard, cover life science tools and diagnostics. It is a real pleasure to have Exact Sciences back with us at the conference this year. Joining us for this conversation, CFO, Aaron Bloomer as well as Derek Leckow, new Head of IR in the audience. Aaron, thanks for being here.
Aaron Bloomer
Chief Financial Officer
Thanks so much for having us. Great to be here.
Question-and-Answer Session
Brandon Couillard
Wells Fargo Securities, LLC, Research Division
Never short of things to talk about when it comes to Exact. We’ll get to all those things. I do want to just kind of focus on maybe to start with fundamentals in 2Q, which were kind of overshadowed by Freenome from which we’ll get to, of course, Cologuard growth accelerated for the second straight quarter, you’re up like 18% year-over-year. Guide implies you kind of exit the year at a high teens clip. Cologuard Plus pricing is part of that. Can you just kind of unpack the drivers of that acceleration, different programs and buckets and sustainability of each of those would look at kind of the next few quarters.
Aaron Bloomer
Chief Financial Officer
We’re really pleased with the progress that we’ve seen in terms of driving increased Cologuard adoption and getting more and more patients screened for CRC. This is part of the broader network effect that we’ve built over the course of the last decade, whether that’s our field force, which we’ve built up our record number of
#Exact #Sciences #Corporation #EXAS #Presents #Wells #Fargo #20th #Annual #Healthcare